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Abstract 
Introduction: Fractional exhaled nitric oxide (FENO) is a non-invasive marker of airway inflammation. 
Measuring FENO at several flow rates enables the calculation of flow independent NO-parameters (alveolar 
NO concentration (CANO), bronchial flux of NO (JawNO), bronchial mucosal NO concentration (CawNO) and 
bronchial wall NO diffusion capacity (DawNO)) that are capable of partitioning the source and release 
mechanism of NO from the lower respiratory tract. However, the current literature on repeatability and normal 
variation of the NO-parameters is deficient, and this information is needed to develop the method towards 
clinical use. 
Methods: We calculated NO-parameters in altogether 28 healthy subjects using two different mathematical 
methods and used three different study protocols to investigate: (i) repeatability of two consecutive 
measurements of NO parameters, (ii) within-day variation of the NO-parameters over one working day and 
(iii) day-to-day variation of the NO-parameters between consecutive days during course of a working week.  
Results: JawNO was the most repeatable among the NO-parameters, whereas DawNO and CawNO were notably 
least repeatable. CANO was higher during the second consecutive measurement (1.22 vs 1.57 ppb, p=0.017). 
Both investigated mathematical methods yielded equally repeatable results. JawNO was slightly higher in the 
afternoon compared to morning (716 vs 881 pl/s, p=0.01), but other parameters showed no diurnal variation. 
Upper 95 % limit for the day-to-day difference in the parameters in healthy subjects was about 1.2 ppb in 
CANO, 400 pl/s in JawNO, 92 ppb in CawNO and 16 pl/s/ppb in DawNO. 
Conclusions: This is the first study assessing short-time repeatability of the NO-parameters. Repeatability of 
the NO-parameters was good and day-to-day variation in NO-parameters was quite low. We recommend 
scheduling FENO-measurements at the same time of day, if possible, and in clinical use variation in NO-
parameters above the normal limits found is this study suggest changes in diseases activity. 
This is the accepted manuscript of the article, which has been published in Journal of Breath Research.            
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Introduction 
Measuring fraction of exhaled nitric oxide (FENO) is widely studied and standardized [1,2] with official 
guidelines on its clinical use in diagnosis, monitoring and management of asthma [3,4]. Usually, FENO is 
measured at flow rate of 50 ml/s (FENO50). However, FENO measured at a single flow rate does not tell the 
source of exhaled NO within the lower respiratory tract. Tsoukias & George introduced a two-compartment 
model of NO exchange dynamics of the lungs which is capable of partitioning the source and release 
mechanism of NO from the lower respiratory tract [5] if FENO is measured at multiple flow rates (extended 
FENO-measurement, eFENO-measurement). They also introduced a robust method of estimating alveolar NO 
concentration (CANO, ppb) and bronchial NO flux (JawNO, pl/s) by calculating slope and intercept, 
respectively, of a linear regression line between NO output and exhalation flow rate (T&G-method) [6]. This 
method is a linear approximation of the two-compartment model’s non-linear equation and applies only with 
higher flow rates. Only methods using the non-linear equation of the two-compartment model allow calculation 
of bronchial mucosal NO concentration (CawNO, ppb) and airway diffusing capacity of NO (DawNO, pl/s/ppb) 
and hence the release mechanism of NO from the lower respiratory tract [7]. Högman and Meriläinen 
introduced a simple iteration method based on three flow rates to allow calculation of CawNO and DawNO [8]. 
These two methods have been recommended by the latest technical standard on FENO [1]. 
Extended FENO-measurement has been investigated for two decades, but there is still no clear consensus on 
all the technical aspects. NO-parameters calculated based on eFENO-measurement are known to vary 
depending on mathematical method and flow rates used [9,10], making the comparison of different research 
groups’ results challenging. In addition, repeatability and normal variation of the NO-parameters over time are 
still to be better assessed. The terms repeatability, reproducibility and variation are not always used coherently 
in literature. Repeatability refers to agreement between results of two successive measurements carried under 
the same conditions of measurement while variation refers to difference in two measurements where the cause 
of difference is change in the measured object rather than error in measurement technique. 
To our knowledge, the current literature on eFENO lacks studies assessing repeatability. There are some 
publications on within-day variation [11-13] but sample sizes are relatively small and results from both healthy 
and diseased subjects are combined in some studies. Day-to-day variation has been investigated between two 
consecutive days or two days with a longer interval [10-12,14-17], but there are no studies measuring NO-
parameters on daily basis for several days consecutively. Knowledge on the repeatability of the measuring 
method and normal variation of NO parameters is of great importance for the development of eFENO 
measurement towards clinical applications, as it helps judging whether certain degree of change in NO 
parameters of a patient reflect changes in disease state or merely normal variation. 
The purpose of this study was to determine the repeatability of eFENO-measurement and normal variation over 
time of the NO-parameters. This study had three different study protocols to investigate: (i) repeatability of 
two consecutive eFENO-measurements, (ii) within-day variation of the NO-parameters over one working day 
and (iii) day-to-day variation of the NO-parameters between consecutive days in course of a working week.  
Methods 
Subjects 
All subjects were adults (over 18 years), non-smoking and healthy with regard to respiratory diseases and free 
of respiratory tract infections for at least 4 weeks. Subjects were asked not to eat, drink caffeinated beverages 
or heavily exercise within one hour prior the measurements. All subjects gave their written informed consent 
and the study was approved by the ethics committee of Tampere University Hospital (R17076). 
Extended FENO-measurement 
FENO was measured using an ozone-chemiluminescence analyzer (NOA 280, Sievers Instruments, Boulder, 
CO, USA). The analyzer was calibrated daily by using calibration gas with known NO concentration of 20.5 
ppm (AGA, Lidingö, Sweden). Zero-calibration was run daily using filtered NO-free air. Both calibrations 
were repeated twice successively. Computer controlled flow restrictor was calibrated before every subject at 
flow rates of 100 and 300 ml/s by using a 3 ± 0.03 -liter syringe. Subjects were asked to flush their mouth and 
pharynx with water prior the measurements. Subjects were in a sitting position and were instructed to inhale 
through mouth to total lung capacity and then exhale through the mouthpiece steadily. Mouthpiece with a 
bacterial filter was connected to a computer-controlled flow restrictor [18]. The device measures flow rate in 
real-time and adjusts flow resistance to either increase or decrease the flow towards the target level  to adjust 
for changes in the subjects’ exhalation effort as long as  the mouth pressure remained between 5 and 20 cmH2O 
[19]. Subjects received visual feedback on mouth pressure on a computer screen and were asked to keep the 
pressure steady between 5 and 20 cmH2O. Researcher followed the FENO vs time -curve in real time and 
instructed the subject to maintain the mouth pressure steady until the curve had reached a steady plateau or the 
subject was run out of breath. NO concentration was then read from the plateau and the same flow rate was 
repeated. If a steady plateau was not reached, the subject was allowed to attempt the flow rate third time. If 
still no steady plateau was formed, the flow rate was discarded from the analysis. FENO-measurement was 
performed at eight different flow rates: 10, 20, 30, 50, 100, 200, 300 and 400 ml/s. FENO was measured 2-3 
times at every flow rate and mean FENO at each flow rate was calculated and used as the result. Ambient air 
NO-concentration was measured prior every subject. 
The method of Tsoukias & George (T&G) was used on FENO values at flow rates 100-400 ml/s to calculate 
JawNO and CANO. The linearity of NO-output vs flow rate at flows ≥ 100 ml/s was evaluated and correlation 
factor r < 0.9 was used as an exclusion criterion. Högman & Meriläinen -algorithm (HMA) based on flow rates 
of 10, 100 and 400 ml/s and was used to calculate JawNO, CANO, CawNO and DawNO [20]. HMA has a built-
in quality control and as a further quality control, CANO-values below zero and CawNO > 1000 ppb were 
excluded. 
Study protocols and analyses 
Short-term repeatability of two consecutive eFENO-measurements 
Two eFENO-measurements were performed with only a short few minute break between the measurements if 
needed. NO-parameters were calculated using both HMA and T&G methods. Repeatability of each NO-
parameter was assessed by three ways: calculating coefficient of repeatability (CR), calculating within-subject 
coefficient of variation (CV) and by assessing upper and lower 95% limits of agreement between the first and 
second measurement by Bland-Altman plots. CR describes the confidence interval where the absolute 




, where d1 is the first and d2 the second measurement and n is the number of subjects 
[21]. CV was calculated as CV = within-subject SD / within-subject mean, where SD is standard deviation. 
We also analyzed differences between group means or medians of the NO parameters from two consecutive 
eFENO-measurements by using paired t-test or Wilcoxon’s signed-rank test. To compare the repeatability of 
the two used methods (T&G and HMA), the CV-values for these methods were compared by paired t-test or 
Wilcoxon’s signed-rank test.  
Within-day variation of the NO-parameters during working day 
Within-day variation of the NO-parameters during a working day was investigated by measuring eFENO three 
times in course of one working day. Measurements were performed between 7:00-10:00, 10:00-13:00 and 
13:00-16:00. There was at least a two-hour gap between measurements in each subject. The variation of the 
NO-parameters during the day was evaluated by calculating CV. The differences in parameter means or 
medians between different times of day were assessed with a repeated measures one-way ANOVA 
(Greenhouse-Geisser correction was used if the data violated the assumption of sphericity) or non-parametric 
Friedmans’s 2-way ANOVA by ranks.  
Day-to-day variation of the NO-parameters between consecutive days in course of one week 
eFENO was measured on 3-5 separate days during one working week and most of the subjects were able to 
participate on 4 consecutive days. The measurements were performed at the same time daily for each subject 
to overcome possible effects of diurnal variation. The differences in parameter means or medians between 
different consecutive days were assessed using a generalized linear mixed model, with the measurement 
session set as a fixed effect factor. Some subjects had only 3 measurements and repeated ANOVA or 
Friedman’s test would have excluded subjects with missing data entirely from the analyses. To compare the 
day-to-day variation of the two methods used (T&G and HMA), the mean CV-values obtained by these 
methods were compared by paired T-test or Wilcoxon’s signed-rank test.  
Day-to-day variation was also assessed by calculating variation coefficient: v = 1.96√2 ∗ 𝑆𝑆𝑆𝑆, where Sv is 
variation standard deviation. Sv was calculated as: 𝑆𝑆𝑆𝑆 = �∑ 𝑠𝑠𝑖𝑖2/𝑝𝑝
𝑝𝑝
𝑖𝑖=1  , where Si is within-subject standard 
deviation and p is number of subjects.  
Sample sizes and tests for normality 
Required sample sizes for the study protocols were calculated based on an allowance of 5 % α-error and 90 % 
statistical power in detecting differences between measurements that are 0.25 times the population’s standard 
deviation. Based on this, sample sizes of 22, 11 and 8 subjects were aimed for in testing repeatability, with-in-
day and day-to-day variation, respectively. Shapiro-Wilk’s test was deployed to test for the normality of the 
parameters. All statistical analysis was calculated using IBM SPSS. NO-parameters were calculated using 
Microsoft Excel. Bland-Altman -plots were drawn with R package “blandr” [22].  
Results 
Altogether, 28 subjects participated in this study and most of them participated in more than one protocol. 
Subjects were mostly young adults (subject characteristics in Table 1). Ambient air NO-concentration was on 
average 0.47 ± 0.56 ppb and free of within-day variation and 2.5 ppb at highest during the measurements 
included in analyses. On one occasion ambient air NO-concentration was 114 ppb but results obtained on that 
day were excluded from the analyses.  
 











n (m/f) 25 (16/9) 14 (9/5) 13 (8/5) 
Age (years)* 24 20–64 23 21–50 24 20–34 
Height (cm) 174 ± 9.98 175 ± 10.6 177 ± 8.9 
Weight (kg) 71.0 ± 9.50 72 ± 10.5 70.9 ± 10.1 
*Age presented as median min–max, other variables as mean ± SD 
 
Repeatability between two consecutive eFENO-measurements 
JawNO and single FENO-values were most repeatable regarding the within-subject CV-values (Table 2). CV of 
JawNO was smallest among the parameters calculated with both methods (HMA and T&G). CV of DawNO and 
CawNO were notably higher than CV of the other parameters. There was no statistically significant difference 
in repeatability of the NO parameters between the two mathematical methods (HMA and T&G) based on 
within-subject CVs obtained (JawNO p = 0.741, CANO p = 0.058). Also, CR related to measured means was 
distinctly smaller in JawNO compared to the other parameters.  
CANO was on average higher at the second measurement (T&G p = 0.017, HMA p = 0.028). JawNO showed 
also an increasing trend between the two measurements, but the difference was not statistically significant. 
FENO10 and FENO400 were also statistically significantly higher during the second measurement (p = 0.001, p 
< 0.001). Figures 1 and 2 present the Bland-Altman plots for the repeatability of the parameters and eFigure 1 
in e-supplement present these for single FENO-values.  
 
 
Table 2. Repeatability of the NO-parameters between two consecutive eFENO-measurements. 





 Limits of 
agreement* CR
¤ 
JawNOT&G (pl/s) 25 907 ± 418 922 ± 418 0.218 4.5% ± 4.7% -154–119 142 
CANOT&G (ppb) 25 1.22 (0.98–2.00) 1.57 (1.19–1.92) 0.017† 9.6% ± 7.7% -0.76–0.41 0.729 
JawNOHMA (pl/s) 21 850 ± 397 864 ± 383 0.526 4.5% ± 2.9% -173–144 157 
CANOHMA (ppb) 21 1.14 (0.83–1.73) 1.26 (0.97–1.95) 0.028† 13.7% ± 14.3% -1.15–0.71 1.00 
CawNOHMA (ppb) 21 115 (79.9–124) 138 (97.2–215) 0.073 14.9% ± 12.2% -259–178 227 
DawNOHMA 
(pl/s/ppb) 
21 7.28 ± 3.46 6.80 ± 4.04 0.280 17.0% ± 14.5% -4.92–5.88 5.36 
FENO10 (ppb) 23 66.6 ± 31.5 70.5 ± 33.4 0.001† 3.6% ± 2.4% -13.0–5.21 11.7 
FENO50 (ppb) 25 19.4 ± 8.58 19.8 ± 8.27 0.175 3.4% ± 3.0% -3.32–2.49 2.96 
FENO400 (ppb) 25 3.83 ± 1.46 4.03 ± 0.339 <0.001† 3.9% ± 3.3% -0.66–0.27 0.601 
#  CV Coefficient of variation, ¤ CR Coefficient of repeatability, * Limits of agreement from the Bland-Altman -analysis, 




Figure 1. Bland-Altman plots of CANO and JawNO from two consecutive measurements using T&G-method. 
 
Figure 2. Bland-Altman plots of JawNO, CANO, CawNO and DawNO from two consecutive measurements using 
HMA-method. 
 
Within-day-variation of the NO-parameters over a working day 
A small but statistically significant increase was observed in JawNO during a working day. JawNO was 166 pl/s 
higher in afternoon compared to morning (p = 0.024) with the T&G-method and 223 pl/s with the HMA-
method (p = 0.023). There were no significant differences in other calculated NO-parameters between different 
times of day (Table 3 and Figures 3-4). FENO10 was also increased in the afternoon compared to morning 





















subject CV  
JawNOT&G (pl/s) 12 716 ± 387 819 ± 458 881 ± 425 0.01† 13.7% ± 6.7% 
CANOT&G (ppb) 12 1.90 ± 0.81 1.68 ± 0.70 1.90 ± 0.66 0.387 16.0% ± 10.8% 
JawNOHMA (pl/s) 12 781 ± 344 939 ± 425 1005 ± 389 0.005† 14.3% ± 7.3% 
CANOHMA (ppb) 12 1.62 ± 0.86 1.15 ± 0.54 1.40 ± 0.72 0.236 35.8% ± 17.7% 
CawNOHMA (ppb) 12 135 94.1 183 143 73.5/208 126 85.9/299 0.920 29.4% ± 20.5% 
DawNOHMA 
(pl/s/ppb) 
12 5.20 3.20/8.40 5.93 3.53/7.78 5.90 4.65/12.32 0.205 30.3% ± 14.6% 
FENO10 (ppb) 14 59.0 ± 27.6 65.9 ± 34.3 69.0 ± 32.8 0.038† 10.2% ± 5.8% 
FENO50 (ppb) 14 16.7 ± 7.9 18.5 ± 9.3 19.7 ± 8.7 0.051 9.0% ± 7.4% 
FENO400 (ppb) 14 3.49 ± 1.33 3.49 ± 1.38 3.71 ± 1.23 0.366 9.8% ± 4.6% 




Figure 3. Diurnal variation of the NO-parameters calculated with T&G-method.  
Figure 4. Diurnal variation of the NO-parameters calculated with HMA-method. 
Day-to-day variation of the NO-parameters between consecutive days in course of one 
working week 
No statistically significant difference was observed in any calculated NO-parameters between the 
measurements at consecutive days (Table 4, e-Figure 3-5). Naturally, the within-subject CV-values seemed 
clearly higher compared to the short-time study protocols, especially when HMA was used to calculate the 
parameters. HMA yielded significantly higher within-subject CV-values for CANO than T&G (p = 0.001) but 
the within-subject CV-values of JawNO showed no difference (p=0.285). Variation coefficient of JawNO was 
clearly smallest when compared to its mean. On the other hand, variation coefficients of DawNO and CawNO 
were even larger than their mean values. Variation coefficients seemed smaller when the parameters were 








Table 4. Day-to-day variation of the NO-parameters. 
Variables n Within-subject CV 




JawNOT&G 13 15.4% ± 8.4% 767 pl/s 295 pl/s 
CANOT&G 13 19.2% ± 11.4% 1.6 ppb 1.17 ppb 
JawNOHMA 12 16.0% ± 9.3% 855 pl/s 397 pl/s 
CANOHMA 12 38.0% ± 21.4% 1.02 ppb 1.20 ppb 
CawNOHMA 12 31.1% ± 13.1% 86 ppb 92.1 ppb 
DawNOHMA 12 36.6% ± 19.0% 12.8 pl/s/ppb 15.7 pl/s/ppb 
FENO10 13 13.0% ± 6.8% 53.6 ppb 21.9 ppb 
FENO50 13 9.9% ± 4.0% 15.5 ppb 4.10 ppb 
FENO400 13 9.4% ± 5.9% 3.08 ppb 1.12 ppb 
* variation coefficient: v = 𝟏𝟏.𝟗𝟗𝟗𝟗√𝟐𝟐 ∗ 𝑺𝑺𝑺𝑺, where 𝑺𝑺𝑺𝑺 = �∑ 𝒔𝒔𝒊𝒊𝟐𝟐/𝒑𝒑
𝒑𝒑
𝒊𝒊=𝟏𝟏  and where Si is 
within-subject standard deviation and p is number of subjects. Results reported as 
mean ± SD or mean. 
 
Discussion 
To develop eFENO-measurement towards clinical applications, it is important to know the repeatability of the 
method and normal variation of the NO-parameters. In this study we found that repeatability of eFENO-
measurement was good and day-to-day variation of NO-parameters in healthy subjects was quite low. The 
most repeatable NO-parameter was JawNO, whereas DawNO and CawNO were notably least repeatable and most 
variable. No significant difference between the two methods (HMA and T&G) was observed when comparing 
their repeatability. A small difference was observed between the morning and afternoon JawNO-values, but the 
other parameters showed no significant change during one working day. As might be expected, no differences 
between the consecutive days during working week were discovered.  
Repeatability 
CANO, FENO10 and FENO400 were on average higher at the latter consecutive eFENO-measurement, while there 
was no such difference in other NO-parameters. One explanation for the increase in CANO, FENO10 and 
FENO400 during the second measurement is that they all involve the most challenging flow rates for the subject: 
FENO10 requiring the longest steady blow and FENO400 usually requiring emptying one’s lung capacity to the 
most. The problem with the flow rates that require emptying one’s lung capacity to the most is that the FENO 
vs time curve does not always reach a steady plateau but instead may form a declining profile. Estimating 
plateau becomes more inaccurate and if the subject was fatigued during the latter measurement and performing 
shorter blows, estimated FENO-plateau could have been higher. Calculation of CANO is highly dependent on 
FENO at the highest flow rate used and the above mentioned phenomenon may have resulted in higher CANO 
during the second measurement.  
Ascending or descending of the FENO-plateau as the subject fatigues depends on the shape of the FENO vs 
time curve. If the curve is declining in profile, the plateau of FENO remains at higher level as subject fatigues 
and performs shorter blows. We often noticed FENO vs time -curve to be declining in the higher flow rates. 
This is because as the subject begins to blow, higher NO levels from the oropharynx and upper airways create 
a peak in the beginning of the NO-curve. When subject exhales through the mouthpiece, air from less NO-rich 
peripheral part of the lung dilutes the NO-concentration, creating a declining curve finally reaching a steady 
plateau. However, this applies better for the higher flow rates when measured FENO is low and could explain 
increase in CANO as calculation of CANO is highly dependent on FENO measured at the higher flow rates.  
JawNO was most repeatable among the NO-parameters. This may be due to that JawNO is calculated using the 
easily performed flow rates (100-400 ml/s) and it shows least variation when different combinations of flow 
rates are used [10] and thus one unsuccessful measurement point may not have had such significant effect on 
JawNO. This could explain why a significant increase in JawNO was not observed even if elevated CANO was 
caused by fatigued subjects. On the other hand, DawNO and CawNO were the least repeatable as calculation of 
these depend heavily on FENO measured at the low flow rates (10 ml/s in this study).  
No statistically significant difference was observed in repeatability between the compared methods. However, 
CVs of CANO were almost statistically significantly higher with HMA compared to T&G (p = 0.058). We 
believe that the reason behind this lies in the number of used measurement points in the parameter calculation. 
HMA uses 3 flow rates whereas T&G uses 4 in this study. With less measurement points, inaccuracy in the 
parameter estimation increases, possibly explaining the higher CV values. Secondly, CANO was less repeatable 
compared to JawNO with both estimation methods. 
In this study, the subjects were mostly young, healthy and well cooperative. Nevertheless, the FENO-
measurements were sometimes found challenging to perform, especially the extremely low and high flow rates. 
The low flow rates (10–20 ml/s) seemed to cause most difficulties. The low flow rates required sometimes 
long periods (up to 60 seconds) of slow and steady exhalation and subjects run out of breath before reaching a 
steady plateau. Sometimes subjects found it difficult to keep their tongue and pharynx steady during the low 
flow rates. Movement of tongue caused peak in the FENO vs time -curve and it hindered the formation of a 
steady plateau. Some subjects had also problems with the highest flow rate (400 ml/s). This was probably due 
to the lack of enough lung capacity for steady plateau to form. Subjects felt fatigued especially during the low 
flow rates of the second consecutive measurement and sometimes air tended to leak between lips and mouth 
piece. These problems emerge especially in a research protocol like this where two consecutive series of 
eFENO-measurements with 8 flows are done. In clinical use, one eFENO-measurement with less flows is surely 
easier for subjects to perform.  
The latest technical standard on FENO measurement suggests using HMA and T&G methods for calculating 
NO parameters. These methods require flow rates of 10, 100 and 400 ml/s, and 100 – 400 ml/s, respectively. 
As this study was originally designed and initiated before the publication of the ERS technical standard, we 
had included also flow rates of 20 and 30 ml/s to the protocol. These were among the most challenging flow 
rates for subjects to perform and they unnecessarily exhausted the subjects and may have increased variation 
to the results.  
To our knowledge, this is the first study investigating short time repeatability of the NO-parameters in healthy 
subjects. FENO50-measurement has already been investigated and it is known to be highly repeatable [23], 
reproducible and free of within-day and day-to-day variation [23,24]. 
Within-day variation 
We observed a small increase in JawNO towards afternoon. We can only speculate the reason for increase in 
JawNO during a working day in this study. JawNO is determined by CawNO and DawNO, of which both showed 
a mild but not significant increase during the day. Possible increase in CawNO might be related to circadian 
rhythm of cortisol level (NO synthesis by iNOS is downregulated by glucocorticoids [25]) and the peak for 
cortisol secretion is about at the time of waking up [26]. Also, daytime exposure to different inhaled irritants 
might trigger inflammatory responses in airway epithelium and traffic related air pollutants are known to cause 
inflammation in peripheral airways and increased CANO-levels [27]. Other possible biological explanations 
could be related to subjects’ diet. Up to 89 % increased FENO-levels are measured after nitrate rich meal and 
half of the subjects had increased FENO-levels even 3 hours after the meal [28]. Oral sodium nitrate intake has 
been noticed to increase NO-parameters JawNO and CANO [29]. In this study, we instructed the subject to 
refrain from eating at least 1 hour prior the measurement. Chlorhexidine wash is noticed to lower JawNO and 
normalize CANO after nitrate intake [29] but in this study, we used water for mouth wash prior the 
measurement. Day-time nitrate intake is one potential factor explaining our findings. Finnish breakfast usually 
consists of carbohydrate rich food (e.g. porridge, bread) low on nitrates. Nitrate intake during lunch may have 
increased the afternoon FENO and thus JawNO levels. Changes in DawNO are more complex since DawNO is 
determined by both physical diffusivity of NO in airway mucosa and also the surface area of airway mucosa 
contributing to NO production [5]. Theoretically the same inhaled irritants that trigger inflammatory activity 
to enhance NO production might increase DawNO by activating iNOS also in more peripheral parts of airways 
and by increasing the surface area of NO production.  
In addition to biological explanations, there is also theoretical possibility of calibration drift. However, we 
consider this quite unlikely. Ambient air NO-concentration was very low (0.47 ± 0.56 ppb) and was free of 
diurnal variation. Theoretically, ambient air NO could have decreased during the day, masking upward 
calibration drift. However, the NO-concentration in the morning was so low that possible decrease in ambient 
air NO during the day would be insufficient to mask such high calibration drift causing the observed increase 
in the NO-parameters.  
To our knowledge, there are only a few studies investigating diurnal variation of the NO-parameters in healthy 
subjects. Brindicci et al. observed no significant diurnal variation in the NO-parameters, but the sample size 
was relatively small (n=9) [11]. In another study, asthmatics were mixed with healthy subjects but still no 
significant diurnal variation was observed [12]. On the other hand, Duong et al. noticed a significant increase 
in CANO and FENO50 between 8 p.m. and 6. a.m. of the day after [13]. Circadian variation of FENO50 has been 
investigated in more detail in healthy and asthmatic subjects and no statistically significant variation has been 
observed [24,30-32]. In these studies, FENO50 seems to have a decreasing trend during the day. Circadian 
variation in healthy subjects’ sputum and blood eosinophils have also been studied but no significant variation 
has been observed [33]. 
According to our results, it would be recommended to schedule eFENO-measurements at the same time of day 
for each patient in future studies to overcome the possible bias caused by normal within-day variation. 
Scheduling of the eFENO-measurement becomes especially important if eFENO-measurement would be used 
to follow up treatment responses. However, the possible normal diurnal rhythm of the NO-parameters still 
needs to be further studied as the current literature has somewhat conflicting results.  
Day-to-day variation 
As expected, day-to-day variation seemed notably higher than the variation of two consecutive measurements. 
JawNO among single FENO-values had least day-to-day variation compared to other parameters. DawNO and 
CawNO had relatively high variation coefficients, and thereby changes in these variables in subjects with 
pulmonary disease need to be quite large to be differentiated from normal variation. JawNO and CANO on the 
other hand had lower variation coefficients, making these more usable for clinical use. CV for CANO seemed 
clearly higher with HMA compared to T&G. We believe that the amount of measurement points explains 
differences between these methods’ CVs as discussed above. In clinical practice the method should be selected 
based on whether interest lies on JawNO and CaNO only (T&G is enough and may have less variation 
regarding CaNO) or if also CawNO and DawNO are needed (HMA should be used). No differences were 
observed in average values of the NO parameters between the consecutive days. To our knowledge, day-to-
day variation of the NO-parameters has not been previously studied. However, FENO measurements have been 
noticed to have low variability when measured in 6 consecutive days in both healthy and asthmatic subjects 
[34]. 
Variation of the NO-parameters over varying time scales have been investigated in multiple studies. They all 
state that all the NO-parameters have little variation over time and it seems that JawNO has least variation, 
whereas CANO and the other parameters show greater variation over time [11,12,15-17,35]. Some studies 
investigated only CANO and the variation was shown to be low [14,36]. Single FENO-values seemed less 
variable than the NO-parameters and this is possibly due to that the NO-parameters are calculated from 
multiple FENO-measurements and inaccuracy accumulates when multiple measurement points, each having 
their own random error, are used. This is especially an issue with DawNO and CawNO that are calculated based 
on an exponential function. 
One potent source of error is that the subjects had different eating and exercise habits prior the measurements 
in consecutive days and this may have increased the observed inter-day variation. Subjects were instructed to 
avoid eating and heavily exercise at least one hour prior the eFENO-measurements. Physical exercise is known 
to influence the NO-parameters. Shin et al. found DawNO to increase, whereas JawNO and CANO were 
decreased after high-intensity exercise [37]. JawNO and CANO are also noticed to decrease in marathoners after 
a marathon run but on the other hand, these marathoners had higher baseline levels of CANO and JawNO [38]. 
There are also studies reporting no change in FENO-levels after exercise [39] and the current literature overall 
is somewhat conflicting. However, exercise is reported to have both acute and long-term effects on the NO-
parameters. Acute effects were tried to be minimized by avoiding exercise in one hour prior measurements. In 
clinical use, patients should be asked about their exercising habits 
Some bias may arise from that the subjects learned to perform the FENO-measurement better during the study. 
This was especially true for the subjects that participated in more than one study protocol and this could be 
especially noticeable with the extreme flow rates. The possible learning effect may become a problem if the 
subject performs the eFENO-measurement multiple times and treatment is tailored according to changes in the 
results or disease progression is monitored with repetitive measurements. However, no difference in average 
values of the parameters was noticed between the consecutive days, which speaks against the possible learning 
effect. Kharitonov et al. investigated the learning effect in FENO-measurement but no significant effect was 
observed [24]. However, asthmatic subjects seemed to have a decreasing trend during the consecutive 
measurement situations.  
Future research 
Preferably our findings on repeatability and normal variation of NO parameters should be confirmed in another 
study. On top of only verifying the results in healthy subjects, further studies in subjects with different 
pulmonary diseases are needed to assess the relation between change in NO parameters and change in disease 
activity or disease progression. 
Conclusion 
In conclusion, short-term repeatability of eFENO-measurement was good and day-to-day variation in NO-
parameters in healthy subjects was quite low. Of the NO-parameters, JawNO was the most repeatable, whereas 
DawNO and CawNO were notably least repeatable. Both investigated methods (T&G and HMA) yielded equally 
repeatable results in short-term, but within-subject CV for CANO was higher with HMA than with T&G. A 
small difference between morning and afternoon values of JawNO and FENO50 was observed and if possible, 
we recommend scheduling repeated FENO-measurements at the same time of day. The upper 95 % limit for 
normal day-to-day variation in NO parameters was about 1.2 ppb in CANO, 400 pl/s in JawNO, 92 ppb in 
CawNO or 16 pl/s/ppb in DawNO. In clinical use a between-visits change in NO parameters above these limits 
suggest changes in diseases activity. 
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